Paasa Logo
Alto Neuroscience, Inc. logo
ANRONYSEMarket closedOpens 9:30am ET

Alto Neuroscience, Inc.

$26.66Last updated
+$0.17 (0.64%)Past day
Timezone

Alto Neuroscience, Inc. (NYSE: ANRO) is trading at $26.66, about ₹2,561 at today's USD/INR rate, as of 28 Sep 2026, 4:00 PM ET, up 0.64% today. Indian residents can buy Alto Neuroscience from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$26.36
Previous close:$26.49
Volume:586.99K

Today's low

$25.77

Today's high

$27.76

52 week low

$3.91

52 week high

$37.48

ANRO opened at $26.36, closed previously at $26.49, and has traded between $3.91 and $37.48 over the past 52 weeks.

About

Alto Neuroscience, Inc. operates as a biopharmaceutical entity in the clinical stage, specializing in the creation of novel psychiatric medications. Its development pipeline includes ALTO-100, an investigational therapy targeting individuals affected by major depressive disorder (MDD) and post-traumatic stress disorder. Also in its portfolio is ALTO-300, a small molecule designed to function as both a melatonergic agonist and serotonergic antagonist, exhibiting antidepressant properties for MDD patients. For addressing the cognitive impairments linked with schizophrenia, Alto Neuroscience is advancing ALTO-101, an innovative small molecule phosphodiesterase 4 inhibitor. The company's therapeutic candidates further extend to ALTO-203, a pioneering small-molecule histamine H3 receptor inverse agonist intended for MDD patients experiencing heightened anhedonia, and ALTO-202, an orally available antagonist of the GluN2B subunit of the NMDA receptor, also under investigation for MDD. Beyond these individual drug candidates, the firm is engaged in developing novel drug combinations that demonstrate synergistic pharmacodynamic effects. Crucially, Alto Neuroscience leverages an advanced AI-enabled biomarker platform that synthesizes data concerning patients' brain activity and behavioral patterns. This platform's purpose is to accurately identify which individuals are most likely to respond positively to its cutting-edge product candidates. Alto Neuroscience, Inc., established in 2019, maintains its headquarters in Los Altos, California.

Country
US
CEO
Amit Etkin
Exchange listed on
NYSE
Industry
Biotechnology
Base currency
USD
Full Time Employees
68
Sector
Healthcare
IPO date
02/02/2024

Key statistics

Avg. volume

520.95K

Market cap

$935.60M

P/E Ratio

-10.75

Price-to-sales ratio

0.00

Enterprise value

$698.92M

Free cash flow yield

-7.36%

Debt-to-equity ratio

0.03

Return on equity

-46.46%

ROIC

18.43%

Beta

1.16

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$0.00

Earnings per share

-$2.19

Free cash flow

-$51.79M

Net profit margin

0.00%

Gross margin

0.00%

EBITDA

-$60.11M

Revenue growth

—

Similar securities

This is not an investment recommendation

How to buy Alto Neuroscience from India

Indian residents can buy Alto Neuroscience shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for Alto Neuroscience and place an order

    Find Alto Neuroscience by name or by its ticker, ANRO, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Alto Neuroscience trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Alto Neuroscience position in USD and INR. Alto Neuroscience pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Alto Neuroscience from India

Trading and taxes when buying Alto Neuroscience from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneAlto Neuroscience does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
US estate tax
May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy Alto Neuroscience stock?

Yes. Alto Neuroscience (ANRO) has been listed on the New York Stock Exchange since 2024, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one Alto Neuroscience share cost in rupees?

One Alto Neuroscience share is $26.66 — about ₹2,561 at a USD/INR rate of 96.07 on 28 Sep 2026. Both the Alto Neuroscience price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Alto Neuroscience from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of Alto Neuroscience?

Yes. One Alto Neuroscience share is $26.66, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Alto Neuroscience.

How are gains on Alto Neuroscience shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Alto Neuroscience price. Paasa issues a capital-gains statement for your return.

Does Alto Neuroscience pay a dividend?

No. Alto Neuroscience does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Alto Neuroscience from India?

The New York Stock Exchange trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on Alto Neuroscience shares held from India?

US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.

Do I have to declare Alto Neuroscience shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Alto Neuroscience holding, its cost and its closing value.

How do I sell Alto Neuroscience and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.